Status:
COMPLETED
Creatine, D-Ribose, B1 Vitamin, and B6 Vitamin in Ischemic Heart Disease
Lead Sponsor:
University of Pavia
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Recently, researchers have paid attention to the development of new products such as supplements food and nutraceuticals for identify and develop integrative therapies to be used in cardiovascular dis...
Detailed Description
The investigators will enroll patients with previous acute coronary syndrome treated for at least 30 days by hospital discharge. The treatment regimen of all patients will be optimized in accordance w...
Eligibility Criteria
Inclusion
- All patients presented acute coronary syndrome treated with at least 30 days by hospital discharge
Exclusion
- oncological diseases
- stable atrial fibrillation
- stent in the common core
- patients who are not able to perform physical activities
- patients with documented sustained ventricular arrhythmias
- pregnant women
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2017
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03411369
Start Date
June 1 2016
End Date
November 15 2017
Last Update
January 31 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.